Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report
- 9 June 2013
- journal article
- other
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 31 (2) , 317-318
Abstract
Management of pure red cell aplasia following major ABO-mismatched hematopoietic stem cell transplantation is a therapeutic challenge. Various therapeutic modalities have been tried with variable responses, and patient remains transfusion dependent for a long time. We report here the use of pulsed oral high dose dexamethasone for pure red cell aplasia following ABO-mismatched allogeneic transplant with complete recovery.Keywords
This publication has 11 references indexed in Scilit:
- Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategiesAnnals of Hematology, 2007
- Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantationBone Marrow Transplantation, 2006
- Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemiaBone Marrow Transplantation, 2002
- Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature reviewAnnals of Hematology, 2001
- Pharmacokinetics of High-dose Oral and Intravenous DexamethasoneTherapeutic Drug Monitoring, 1999
- Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietinBone Marrow Transplantation, 1997
- Primary dexamethasone treatment of multiple myeloma.1992
- Case Report: Isoimmune Inhibition of Erythropoiesis Following ABO-Incompatible Bone Marrow TransplantationThe American Journal of the Medical Sciences, 1991
- PURE RED-CELL APLASIA OF LONG DURATION COMPLICATING MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION1990
- Pure red cell aplasia of long duration complicating major ABO- incompatible bone marrow transplantation [see comments]Blood, 1990